Véronique Orian-Rousseau

Deputy Director/ Head of the Biomedical Department

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Tissue Engineering Tissue Engineering professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Véronique Orian-Rousseau serves as the Deputy Director and Head of the Biomedical Department at KIT in Germany. Her research primarily focuses on the role of CD44 in cancer biology, examining its implications in tumor growth, metastasis, and cell interaction. Recent articles explore themes such as stemness in cancer cells, the development of selective estrogen receptor degraders for breast cancer therapy, and the functional characterization of cell surface interactions in various cancer models.

Articles (11)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (7)

Xavier Thuru

Université de Lille

FRANCE

View details

Christian Schwerk

Heidelberg University

GERMANY

View details

Fabien Gosselet

Professeurs des Universités

Université d'Artois

FRANCE

View details

Caroline Mysiorek

Université d'Artois

FRANCE

View details

Xuefen Le Bourhis

Université de Lille

FRANCE

View details

Guillaume Brysbaert

CNRS

FRANCE

View details

Robert-Alain Toillon

Full professor

Université de Lille

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Véronique Orian-Rousseau

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfaces

Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis

CD44: a stemness driver, regulator, and marker—all in one?

Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B

Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy

Automated high-throughput image processing as part of the screening platform for personalized oncology

Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells

Different Involvement of Vimentin during Invasion by <i>Listeria monocytogenes</i> at the Blood–Brain and the Blood–Cerebrospinal Fluid Barriers In Vitro

Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer

CD44 expressed by myeloid cells promotes glioma invasion

Combinatorial Synthesis of a Lipidoid Library by Thiolactone Chemistry: In Vitro Screening and in Vivo Validation for siRNA Delivery

Collaborators (7)

Xavier Thuru

Christian Schwerk

Fabien Gosselet

Caroline Mysiorek

Xuefen Le Bourhis

Guillaume Brysbaert

Robert-Alain Toillon

Make your next move.